Literature DB >> 9916913

Combined morphological and interphase fluorescence in situ hybridization study in multiple myeloma of Chinese patients.

M H Ng1, A Kan, Y F Chung, I H Wong, K W Lo, N W Wickham, K I Lei, J C Lee.   

Abstract

To gain insight into the real incidence of the numeric chromosomal aberrations and the cell lineage involvement of the neoplastic process in multiple myeloma (MM), we examined 18 Chinese MM patients by May-Grunwald-Giemsa (MGG) staining and fluorescence in situ hybridization using three DNA centromeric probes specific for chromosomes 3, 7, and 9. In this investigation, cytogenetic abnormalities were detected in plasma cells (PCs), myeloid cells (MCs), and lymphoid cells (LCs) in all of the MM patients studied. This is the first demonstration of the cytogenetic aberration involved in the myeloid series. Furthermore, the MCs and PCs of 16 MM patients had the same aneuploidies in one or more of the chromosomes analyzed. These data suggest that the neoplastic transformation of MM may occur early in the hematopoietic development. Chromosomal aberrations involving mainly subclones and considerable cellular heterogeneity with gain of a variety of copy numbers of the same chromosome were demonstrated within PCs, which may possibly be the result of an underlying defect of PCs in the control of their number of chromosomes. Whereas PCs showed evidence suggestive of increased polyploidization, MCs and LCs, which exhibited similar chromosomal patterns as the former, rarely did. Thus, the clonal evolution from LC to PC, if that happens in MM, is characterized by chromosomal instability favoring growth of tumor cells with polysomies and polyploidies.

Entities:  

Mesh:

Year:  1999        PMID: 9916913      PMCID: PMC1853428          DOI: 10.1016/S0002-9440(10)65245-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

Review 1.  Myeloma phenotype: clues to disease origin and manifestation.

Authors:  J Epstein
Journal:  Hematol Oncol Clin North Am       Date:  1992-04       Impact factor: 3.722

2.  Simultaneous presentation of acute myelomonocytic leukemia and multiple myeloma.

Authors:  B Cleary; R A Binder; A N Kales; B J Veltri
Journal:  Cancer       Date:  1978-04       Impact factor: 6.860

3.  Simultaneous occurrence of acute myeloblastic leukaemia and multiple myeloma without previous chemotherapy.

Authors:  T Tursz; G Flandrin; J C Brouet; J Briere; M Seligmann
Journal:  Br Med J       Date:  1974-06-22

Review 4.  Multiple myeloma terminating in acute leukemia. Report of 12 cases and review of the literature.

Authors:  F Rosner; H Grünwald
Journal:  Am J Med       Date:  1974-12       Impact factor: 4.965

5.  A case of acute myelomonocytic leukaemia associated with myelomatosis.

Authors:  A C Parker
Journal:  Scand J Haematol       Date:  1973

6.  Philadelphia chromosome in human multiple myeloma.

Authors:  H Van Den Berghe; A Louwagie; A Broeckaert-Van Orshoven; G David; R Verwilghen; J L Michaux; G Sokal
Journal:  J Natl Cancer Inst       Date:  1979-07       Impact factor: 13.506

7.  Interferon beta 2/interleukin-6 and interleukin-3 synergize in stimulating proliferation of human early hematopoietic progenitor cells.

Authors:  R Michalevicz; D Lifshitz; M Revel
Journal:  Scanning Microsc       Date:  1989-12

8.  Markers of multiple hematopoietic-cell lineages in multiple myeloma.

Authors:  J Epstein; H Q Xiao; X Y He
Journal:  N Engl J Med       Date:  1990-03-08       Impact factor: 91.245

9.  A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Authors:  B G Durie; S E Salmon
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

10.  Myelomonocytic antigen positive multiple myeloma.

Authors:  T M Grogan; B G Durie; C M Spier; L Richter; E Vela
Journal:  Blood       Date:  1989-02-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.